COSMOS Pharmaceutical Corporation
CSMYF · OTC
5/31/2025 | 5/31/2024 | 5/31/2023 | 5/31/2022 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $57,038,000 | $52,301,000 | $45,928,000 | $37,362,000 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $12,240,000 | $12,199,000 | $12,650,000 | $10,766,000 |
| Inventory | $92,323,000 | $86,173,000 | $77,479,000 | $66,363,000 |
| Other Curr. Assets | $4,021,000 | $3,660,000 | $13,226,000 | $11,548,000 |
| Total Curr. Assets | $165,622,000 | $154,333,000 | $137,085,000 | $115,471,000 |
| Property Plant & Equip (Net) | $348,162,000 | $295,798,000 | $274,655,000 | $239,035,000 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $446,000 | $497,000 | $547,000 | $433,000 |
| Long-Term Investments | $0 | $0 | $4,310,000 | $4,179,000 |
| Tax Assets | $2,913,000 | $0 | $2,268,000 | $1,966,000 |
| Other NC Assets | $7,608,000 | $25,915,000 | $2,095,000 | $1,966,000 |
| Total NC Assets | $359,129,000 | $322,210,000 | $283,875,000 | $247,579,000 |
| Other Assets | $4,000 | $3,000 | $7,000 | $2,000 |
| Total Assets | $524,755,000 | $476,546,000 | $420,967,000 | $363,052,000 |
| Liabilities | – | – | – | – |
| Payables | $177,125,000 | $179,549,000 | $161,852,000 | $139,224,000 |
| Short-Term Debt | $7,938,000 | $6,512,000 | $4,485,000 | $3,056,000 |
| Tax Payable | $11,651,000 | $5,572,000 | $6,275,000 | $4,995,000 |
| Deferred Revenue | $0 | $0 | $24,801,000 | $18,975,000 |
| Other Curr. Liab. | $23,966,000 | $21,596,000 | $19,441,000 | $14,788,000 |
| Total Curr. Liab. | $220,680,000 | $213,229,000 | $192,053,000 | $162,063,000 |
| LT Debt | $42,019,000 | $27,551,000 | $13,716,000 | $6,357,000 |
| Deferred Rev, NC | $0 | $0 | -$442,000 | -$451,000 |
| Deferred Tax Liab, NC | $0 | $0 | $442,000 | $451,000 |
| Other NC Liab. | $4,593,000 | $4,325,000 | $4,126,000 | $4,125,000 |
| Total NC Liab. | $46,612,000 | $31,876,000 | $17,842,000 | $10,482,000 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $7,073,000 | $6,097,000 | $5,442,000 | $5,026,000 |
| Total Liabilities | $267,292,000 | $245,105,000 | $209,895,000 | $172,545,000 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $4,178,000 | $4,178,000 | $4,178,000 | $4,178,000 |
| Retained Earnings | $248,309,000 | $222,284,000 | $202,485,000 | $181,954,000 |
| AOCI | $0 | $0 | $40,000 | $5,000 |
| Other Equity | $4,975,000 | $4,978,000 | $4,368,000 | $4,369,000 |
| Total Equity | $257,462,000 | $231,440,000 | $211,071,000 | $190,506,000 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $524,754,000 | $476,546,000 | $420,966,000 | $363,051,000 |
| Net Debt | -$7,081,000 | -$18,238,000 | -$27,727,000 | -$27,949,000 |